The role of antiplatelet therapies on incidence and mortality of hepatocellular carcinoma.
Quirino LaiNicoletta De MatthaeisMichele FinottiGiovanni GalatiGiuseppe MarroneFabio MelandroFilomena MoriscoDaniele NicoliniRiccardo PravisaniEdoardo Giovanni Giannininull nullPublished in: European journal of clinical investigation (2022)
Current data suggest that APT correlated with higher HCC incidence and poor overall survival following tumour treatment.